Drent, Esther
25  results:
Search for persons X
?
1

Preclinical Evaluation of Invariant Natural Killer T Cells ..:

Poels, Renée ; Drent, Esther ; Lameris, Roeland...
International Journal of Molecular Sciences.  22 (2021)  3 - p. 1096 , 2021
 
?
5

Preclinical evaluation of invariant natural killer t cells ..:

Poels, Renée ; Drent, Esther ; Lameris, Roeland...
Poels , R , Drent , E , Lameris , R , Katsarou , A , Themeli , M , van der Vliet , H J , de Gruijl , T D , van de Donk , N W C J & Mutis , T 2021 , ' Preclinical evaluation of invariant natural killer t cells modified with cd38 or bcma chimeric antigen receptors for multiple myeloma ' , International Journal of Molecular Sciences , vol. 22 , no. 3 , 1096 , pp. 1-16 . https://doi.org/10.3390/ijms22031096.  , 2021
 
?
 
?
11

Towards safe and effective CD38-CAR T cell therapy for myel..:

Drent, Esther
https://dspace.library.uu.nl/handle/1874/363447.  , 2018
 
?
12

Feasibility of controlling CD38-CAR T cell activity with a ..:

Drent, Esther ; Poels, Renée ; Mulders, Manon J...
Drent , E , Poels , R , Mulders , M J , van de Donk , N W C J , Themeli , M , Lokhorst , H M & Mutis , T 2018 , ' Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design ' , PLoS ONE , vol. 13 , no. 5 , pp. e0197349 . https://doi.org/10.1371/journal.pone.0197349.  , 2018
 
?
 
?
14

Pre-clinical evaluation of CD38 chimeric antigen receptor e..:

Drent, Esther ; Groen, Richard W. J ; Noort, Willy A. Noort...
Drent , E , Groen , R W J , Noort , W A N , Themeli , M , van Bueren , J J L , Parren , P W H I , Kuball , J , Sebestyen , Z , Yuan , H , de Bruijn , J D , van de Donk , N W C J , Martens , A C M , Lokhorst , H M & Mutis , T 2016 , ' Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma ' , Haematologica , vol. 101 , no. 5 , pp. 616-625 . https://doi.org/10.3324/haematol.2015.137620.  , 2016
 
1-15